Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Jennifer J. Wilkes"'
Autor:
Haley Newman, Yimei Li, Yuan‐Shung V. Huang, Caitlin W. Elgarten, Regina M. Myers, Jenny Ruiz, Daniel J. Zheng, Alison Barz Leahy, Catherine Aftandilian, Staci D. Arnold, Kira Bona, M. Monica Gramatges, Mallorie B. Heneghan, Kelly W. Maloney, Arunkumar J. Modi, Rajen J. Mody, Elaine Morgan, Jeffrey Rubnitz, Naomi Winick, Jennifer J. Wilkes, Alix E. Seif, Brian T. Fisher, Richard Aplenc, Kelly D. Getz
Publikováno v:
Cancer Medicine, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Objective Examine the influence of household income on health‐related quality of life (HRQOL) among children with newly diagnosed acute myeloid leukemia (AML). Design Secondary analysis of data prospectively collected from pediatric patien
Externí odkaz:
https://doaj.org/article/9a27bd579aa24883a6ccbfc603b94c45
Autor:
Haley Newman, Yimei Li, Yuan-Shung V. Huang, Caitlin W Elgarten, Regina M. Myers, Jenny Ruiz, Allison Barz Leahy, Catherine Aftandilian, Staci D. Arnold, Kira O Bona, Mallorie M. Heneghan, M Monica Gramatges, Kelly W Maloney, Arunkumar J. Modi, Rajen Mody, Naomi J Winick, Elaine Morgan, Jennifer J. Wilkes, Alix E. Seif, Brian T. Fisher, Richard Aplenc, Kelly D. Getz
Publikováno v:
Blood. 140:11001-11003
Autor:
Caitlin W. Elgarten, William R. Otto, Luke Shenton, Madison T. Stein, Joseph Horowitz, Catherine Aftandilian, Staci D. Arnold, Kira O. Bona, Emi Caywood, Anderson B. Collier, M. Monica Gramatges, Meret Henry, Craig Lotterman, Kelly Maloney, Arunkumar J. Modi, Amir Mian, Rajen Mody, Elaine Morgan, Elizabeth A. Raetz, Anupam Verma, Naomi Winick, Jennifer J. Wilkes, Jennifer C. Yu, Richard Aplenc, Brian T. Fisher, Kelly D. Getz
Publikováno v:
Infection Control & Hospital Epidemiology. 44:222-229
Background:Bloodstream infections (BSIs) are a frequent cause of morbidity in patients with acute myeloid leukemia (AML), due in part to the presence of central venous access devices (CVADs) required to deliver therapy.Objective:To determine the diff
Autor:
Smita Bhatia, Julie A. Wolfson, Paul C. Nathan, Henry J. Henk, David Bernstein, Jill P. Ginsberg, Lena E. Winestone, Kelly M. Kenzik, Laura K. Becker, Gary H. Lyman, Jennifer J. Wilkes, Diane Puccetti
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:142-149
Background: Outcomes among Hodgkin lymphoma (HL) patients diagnosed between 22 and 39 years are worse than among those diagnosed Methods: We examined cancer-related expenditures among 22- to 39-year-old HL patients diagnosed between 2001 and 2016 usi
Autor:
Blake Foxworthy, Elizabeth C Davis, Ana C. Xavier, Julienne Brackett, David Dickens, Alissa R. Kahn, Isaac Martinez, Archana Sharma, Carla Schwalm, Jessica M. Foley, Jennifer J. Wilkes, Smita Bhatia, Jennifer M Levine, Emily Johnston, Julie A. Wolfson
Publikováno v:
Blood. 140:8030-8031
Autor:
Julie A. Wolfson, Henry J. Henk, Jennifer J. Wilkes, Paul C. Nathan, David Bernstein, Jill P. Ginsberg, Laura Becker, Lena E. Winestone, Kelly M. Kenzik, Smita Bhatia, Gary H. Lyman, Diane Puccetti
Publikováno v:
Cancer. 127:1901-1911
BACKGROUND Individuals diagnosed with acute lymphoblastic leukemia (ALL) between the ages of 22 and 39 years experience worse outcomes than those diagnosed when they are 21 years old or younger. Treatment at National Cancer Institute-designated Compr
Autor:
Tamara P Miller, Kelly D Getz, Yimei Li, Biniyam G Demissei, Peter C Adamson, Todd A Alonzo, Evanette Burrows, Lusha Cao, Sharon M Castellino, Marla H Daves, Brian T Fisher, Robert Gerbing, Robert W Grundmeier, Edward M Krause, Judy Lee, Philip J Lupo, Karen R Rabin, Mark Ramos, Michael E Scheurer, Jennifer J Wilkes, Lena E Winestone, Douglas S Hawkins, M Monica Gramatges, Richard Aplenc
Publikováno v:
The Lancet. Haematology. 9(9)
Adverse events are often misreported in clinical trials, leading to an incomplete understanding of toxicities. We aimed to test automated laboratory adverse event ascertainment and grading (via the ExtractEHR automated package) to assess its scalabil
Autor:
Matthew A. Eisenberg, Ruth Riggs, Raina Paul, Fran Balamuth, Troy Richardson, Heidi G. DeSouza, Mary Kate Abbadesa, Theodore K.M. DeMartini, Meg Frizzola, Roni Lane, Julia Lloyd, Elliot Melendez, Nikhil Patankar, Lori Rutman, Amanda Sebring, Zebulon Timmons, Halden F. Scott, Jeffery J. Auletta, Katie Barchi, Benjamin R. Braun, Richard J. Brilli, Deborah R. Campbell, Richard E. Chinnock, Jacqueline B. Corboy, Holly E. Depinet, Jill Dykstra-Nykanen, Karen A. Genzel, Hana Hakim, Jonathan D. Hron, Leslie A. Hueschen, W. Charles Huskins, Sarah B. Kandil, Yu Kawai, V. Matt Laurich, Jeremy M. Loberger, Charles G. Macias, Joan E. Mackenzie, Elizabeth H. Mack, Ashish S. Nagpal, Matthew Niedner, Daniel B. Park, Faisal Razzaqi, Wendi S. Redfern, Johanna R. Rosen, Ranna A. Rozenfeld, Sam Selby, Matthew P. Sharron, Jonathan A. Silverman, Lawrence D. Spack, Erika L. Stalets, Roopa Thukaram, Beth A. Wathen, Jennifer J. Wilkes, Jennifer K. Workman, Jennifer C. Zuccaro
Publikováno v:
Annals of emergency medicine. 80(3)
To determine whether the receipt of more than or equal to 30 mL/kg of intravenous fluid in the first hour after emergency department (ED) arrival is associated with sepsis-attributable mortality among children with hypotensive septic shock.This is a
Bilateral Pseudo-hypopyon as Presenting Symptom of Acute Monocytic Leukemia in an 8-Month-Old Infant
Autor:
Mallory R Taylor, Erin P. Herlihy, Karen M Chisholm, Kristina Tarczy-Hornoch, Shu Feng, Nicholas M. Scoville, Jennifer J Wilkes
Publikováno v:
Journal of Pediatric Ophthalmology & Strabismus. 58
A previously healthy 8-month-old female infant presenting with lethargy and bilateral eye redness and cloudiness had bilateral hypopyon uveitis, which persisted despite topical steroids. Cytology of the anterior chamber and cerebrospinal fluid and fl
Autor:
Lena E. Winestone, Jennifer J. Wilkes, Henry J. Henk, Laura Becker, Eric J. Chow, Gary H. Lyman, Pamela E Morin
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:HSR19-090
Background: Chronic myeloid leukemia (CML) treatment improved considerably after introduction of oral tyrosine kinase inhibitors (TKI). As a result, the number of patients living with CML may reach 250,000 by 2040. We track changes in TKI treatment a